look news india
Cancer vaccine: Could be revolutionary in skin cancer treatment. The world's first individually designed mRNA cancer vaccine, designed to treat melanoma, is being tested on patients in the UK. This 'gamechanger' vaccine is said to help prevent not only melanoma but also bladder, lung and kidney cancer in the future.
According to a BBC report, the special thing about this vaccine is that it has been made individually for each patient. This vaccine gives a message to the body to recognize cancer cells and fight them. It also reduces the risk of cancer recurring in the future. A recent Phase 2 trial found that the vaccine significantly reduced the risk of cancer coming back in melanoma patients. After these good results, now the final testing of this vaccine has started.
expert opinion
University College London Hospitals NHS Foundation Trust (UCLH) is leading the trial. “This is one of the most exciting things we’ve seen in a long time,” said co-investigator Dr. Heather Shaw. He said it's a really cool tool. Be able to let your patients know that you are offering them something more effective than standard cancer treatments. It's the same level of expertise that they're getting. These vaccines are highly technical and tailored for each patient according to their condition. Patients say they are very excited about it.
hope for the future:
If the final phase of testing is also successful, this vaccine can prove to be a milestone in the treatment of skin cancer. Also, this could also be a new beginning in the field of individually designed vaccines. In the future, this technology can also be used to treat other types of cancer.